A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.


Click here to Search Jobs

Hotbed News
Ebola Clinical Trials: Big Name Players In The Ebola Race Wednesday, October 22, 2014
Enigma Diagnostics Inks Pact, Banks $50 Million Investment Wednesday, October 22, 2014
Semiconductor Company Verisilicon Files For A $75 Million IPO Tuesday, October 21, 2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials Saturday, October 18, 2014
Hangzhou Joinstar And Response Biomedical (RBM.V) In $9 Million Deal Friday, October 17, 2014
China Biologic Products Awarded CFDA Approval To Manufacture Plasma Product Monday, October 20, 2014
GlaxoSmithKline (GSK)'s Hefty Fine Signals No Immunity For Multinationals Monday, September 22, 2014
Emeryville Cancer Drug Developer Eureka Therapeutics Lands $21 Million From Chinese, Other Investors Friday, September 26, 2014
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises Monday, September 29, 2014
BioPharm Executive: Building Biotech's Next Boom Thursday, September 25, 2014

Hotbed Directory